{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:44:46Z","timestamp":1761101086429,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":982,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["T32 HL007093","K23 HL077446","CA18029","DK56465","CA15704"],"award-info":[{"award-number":["T32 HL007093","K23 HL077446","CA18029","DK56465","CA15704"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001021","name":"Damon Runyon Cancer Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.bbmt.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T23:24:53Z","timestamp":1328657093000},"page":"1243-1249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Early CD3 Peripheral Blood Chimerism Predicts the Long-Term Engrafting Unit Following Myeloablative Double-Cord Blood Transplantation"],"prefix":"10.1016","volume":"18","author":[{"given":"Laura F.","family":"Newell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Milano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian B.","family":"Nicoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ted A.","family":"Gooley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Heimfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Delaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2012.01.014_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib2","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1056\/NEJM200106143442402","article-title":"Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors","volume":"344","author":"Laughlin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2012.01.014_bib3","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1182\/blood-2002-01-0294","article-title":"Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and non malignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival","volume":"100","author":"Wagner","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/sj.bmt.1705933","article-title":"Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation","volume":"41","author":"Haspel","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.01.014_bib5","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1182\/blood-2009-07-231068","article-title":"Combined effect of total nucleated cell dose and HLA-match on transplant outcome in 1061 cord blood recipients with hematological malignancies","volume":"115","author":"Barker","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbmt.2009.11.013","article-title":"Cord blood units with low CD34+ cell viability have a low probability of engraftment after double unit transplantation","volume":"16","author":"Scaradavou","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.01.014_bib7","article-title":"Factors predicting single-unit predominance after double umbilical cord blood transplantation","author":"Ramirez","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.01.014_bib8","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood-2010-08-300491","article-title":"Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts","volume":"117","author":"Avery","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib9","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MOH.0b013e32833e5b59","article-title":"Cord blood transplants: one, two or more units?","volume":"17","author":"Avery","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.bbmt.2012.01.014_bib10","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood-2009-07-228999","article-title":"Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit","volume":"115","author":"Gutman","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib11","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3109\/10428191003699886","article-title":"Double umbilical cord blood transplant: more than a cell dose?","volume":"51","author":"Stanevsky","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bbmt.2012.01.014_bib12","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood-2004-04-1506","article-title":"Kinetics of engraftment in\u00a0patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning","volume":"104","author":"Baron","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2004.06.003","article-title":"Kinetics of engraftment following allogeneic hematopoietic cell transplantation with reduced-intensity or nonmyeloablative conditioning","volume":"19","author":"Baron","year":"2005","journal-title":"Blood Rev"},{"key":"10.1016\/j.bbmt.2012.01.014_bib14","doi-asserted-by":"crossref","first-page":"3192","DOI":"10.1182\/blood.V98.12.3192","article-title":"The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation","volume":"98","author":"Ho","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib15","first-page":"445","article-title":"Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants","volume":"3","author":"Martin","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.01.014_bib16","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1182\/blood-2003-05-1601","article-title":"Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation","volume":"103","author":"Kim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib17","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.bbmt.2007.06.010","article-title":"Umbilical cord blood xenografts in immunodeficient mice reveal that T cells enhance hematopoietic engraftment beyond overcoming immune barriers by stimulating stem cell differentiation","volume":"13","author":"Hexner","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.01.014_bib18","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood-2010-03-276212","article-title":"An in\u00a0vivo model of double-unit cord blood transplantation that correlates with clinical engraftment","volume":"116","author":"Eldjerou","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.coi.2006.07.015","article-title":"Double umbilical cord blood transplantation","volume":"18","author":"Majhail","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.bbmt.2012.01.014_bib20","doi-asserted-by":"crossref","unstructured":"Milano F, Heimfeld S, Delaney C, et\u00a0al. Influence of infused na\u00efve CD3+CD8+ and CD3+CD56+ NKT-cells on single unit dominance after double cord blood transplantation. American Society of Hematology, Oral Presentation, 2011; San\u00a0Diego.","DOI":"10.1182\/blood.V118.21.652.652"},{"key":"10.1016\/j.bbmt.2012.01.014_bib21","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2012.01.014_bib22","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.bbmt.2010.05.015","article-title":"Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation","volume":"16","author":"Introna","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2012.01.014_bib23","doi-asserted-by":"crossref","first-page":"e9221","DOI":"10.1371\/journal.pone.0009221","article-title":"High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy","volume":"5","author":"Spanholtz","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2012.01.014_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3324\/haematol.2010.038836","article-title":"An overview of the progress on double umbilical cord blood transplantation","volume":"96","author":"Sideri","year":"2011","journal-title":"Haematologica"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879112000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:41:57Z","timestamp":1761057717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879112000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1083879112000535"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.01.014","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early CD3 Peripheral Blood Chimerism Predicts the Long-Term Engrafting Unit Following Myeloablative Double-Cord Blood Transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2012.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}